FirstHealth Moore Regional Hospital is seeking volunteers for a new oncology research study.
The purpose of the Alliance study is to find out what effects, good and/or bad, the investigational drug (cabozantinib) has on advanced or metastatic kidney cancer and to compare it to the current standard treatment (sunitinib).
To find out if you are eligible, or for more information on clinical trials offered at FirstHealth, call (910) 715-2200.
September 19, 2017
Stand Together & Drink Pink 2017Register in the form provided to host your Drink Pink lemonade stand. To learn more about the Stand Together & Drink Pink campaign, click here. To do…
July 18, 2017
FirstHealth Continues Cancer-Related Insomnia Study with Second Clinical TrialEllen Willard, M.D. PINEHURST – Certain medications, anxiety and “fear of the unknown” are known to contribute to the insomnia that cancer patients e…
June 2, 2016
Summer Skin CareSummer in the Sandhills has arrived and, with the warmer weather, comes outdoor activities – and the occasional sunburn. Skin cancer is the most comm…